Stockreport

Exelixis Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF - Total Revenues of $419.4 million, Cabozantinib Franchise Revenues of $347.0 million -- GAAP Diluted EPS of $0.22, Non-GAAP Diluted EPS of $0.28 -- Conference Call and [Read more]